Skip to main content
MEDIPOSTCO.,LTD. logo

MEDIPOSTCO.,LTD. — Investor Relations & Filings

Ticker · 078160 ISIN · KR7078160009 KO Manufacturing
Filings indexed 366 across all filing types
Latest filing 2025-08-18 Report Publication Anno…
Country KR South Korea
Listing KO 078160

About MEDIPOSTCO.,LTD.

https://en.medi-post.co.kr/

MEDIPOST is a biotechnology company specializing in the research, development, and commercialization of stem cell therapeutics and regenerative medicine. The company focuses on addressing unmet medical needs for incurable diseases through its proprietary stem cell platform technology. Its core operations include a cord blood banking service and the development of allogeneic stem cell therapies. Key commercialized products include CARTISTEM®, a treatment for knee cartilage defects and osteoarthritis, and PNEUMOSTEM®, a preventive therapy for bronchopulmonary dysplasia in premature infants. The company's clinical pipeline features next-generation injectable treatments for conditions such as osteoarthritis and diabetic nephropathy.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is an announcement regarding an upcoming Investor Relations (IR) event (Corporate Day). It provides details such as the date, location, purpose, and agenda for the meeting. Since it is an announcement of an event rather than the presentation slides themselves, and it fits the regulatory disclosure format for IR activities, it is classified as a Regulatory Filing (RNS).
2025-08-18 Korean
반기보고서 (2025.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for Medipost, covering the period from January 1, 2025, to June 30, 2025. It contains detailed corporate information, business descriptions, capital structure, and management details, which are characteristic of a comprehensive interim financial report. It is not an announcement of a report (RPA) as it contains substantive data and is clearly the report itself. H1 2025
2025-08-14 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (Non-Deal Roadshow). It specifies the date, location, target audience, and purpose of the meeting. Since it is an announcement of an event rather than the presentation slides themselves, and it fits the regulatory disclosure format for corporate events, it is classified as a Regulatory Filing (RNS).
2025-07-10 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is an announcement regarding an upcoming Investor Relations (IR) event (Non-Deal Roadshow). It provides details such as the date, location, target audience, and purpose of the meeting. Since it is an announcement of an event rather than the presentation slides themselves, and it is a short regulatory notice, it falls under the category of a general regulatory announcement or event notification.
2025-06-09 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Medipost Co., Ltd. for the period ending March 31, 2025. It contains detailed financial data, business operations, management discussions, and capital structure information. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2025
2025-05-15 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). This document specifically details changes to the company's board of directors, which falls under the category of Board/Management Information.
2025-03-28 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.